For instance, miRNA-mediated downregulation of antigen-processing machinery or MHC class I molecules in tumor cells and dendritic cells (DCs) can impair antigen presentation, limiting recognition of tumor antigens by cytotoxic T lymphocytes (CD8+ T cells) (Table 1 and Figure 1) [10]. This evidence concerns the gene CD8A and neoplasm.